- Home
- LECO vs ARWR Comparison
LECO vs ARWR Comparison
Compare LECO & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LECO | ARWR |
|---|---|---|
| Founded | 1895 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.4B | 12.4B |
| IPO Year | 1994 | 2009 |
Fundamental Metrics
Financial Performance| Metric | LECO | ARWR |
|---|---|---|
| Price | $258.32 | $68.79 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 10 |
| Target Price | ★ $273.67 | $83.40 |
| AVG Volume (30 Days) | 409.6K | ★ 1.6M |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.23% | N/A |
| EPS Growth | 14.36 | ★ 99.80 |
| EPS | ★ 5.34 | N/A |
| Revenue | ★ $3,761,211,000.00 | $16,142,321.00 |
| Revenue This Year | $8.58 | N/A |
| Revenue Next Year | $5.20 | N/A |
| P/E Ratio | $48.17 | ★ N/A |
| Revenue Growth | ★ 16.30 | N/A |
| 52 Week Low | $216.22 | $31.46 |
| 52 Week High | $310.00 | $95.49 |
Technical Indicators
Market Signals| Indicator | LECO | ARWR |
|---|---|---|
| Relative Strength Index (RSI) | 42.89 | 29.45 |
| Support Level | $252.54 | $60.60 |
| Resistance Level | $264.82 | $71.83 |
| Average True Range (ATR) | 7.49 | 3.98 |
| MACD | -1.65 | -2.05 |
| Stochastic Oscillator | 44.28 | 16.52 |
Price Performance
Historical ComparisonAbout LECO Lincoln Electric Holdings Inc.
Lincoln Electric is a leading manufacturer of welding, cutting, and brazing products. Its portfolio includes arc-welding solutions, plasma and oxy-fuel cutting systems, brazing and soldering alloys, and automation solutions. Lincoln Electric serves clients across general fabrication, heavy industries, automotive, construction, shipbuilding, energy, and process industries, among others. The company generated roughly $4.2 billion in sales in 2025.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products and clinical candidates designed to target different cell types within the body.